LINC01102: A Non-coding RNA Molecule Regulating Gene Expression and Cellular Processes

Target Name: LINC01102

NCBI ID: G150568

LINC01102

Other Name(s): long intergenic non-protein coding RNA 1102 | Long intergenic non-protein coding RNA 1102

LINC01102: A Non-coding RNA Molecule Regulating Gene Expression and Cellular Processes

LINC01102 is a long intergenic non-protein coding RNA (lncRNA) with a length of approximately 292 nucleotides. It is a non-coding RNA molecule that is found in various tissues and cells of the human body.

LINC01102 is characterized by its unique structure and the fact that it is not a protein. It is composed of a series of non-coding nucleotides that are arranged in a specific sequence. The sequence of nucleotides in LINC01102 is highly conserved across different organisms, which suggests that it may have a role in gene regulation.

Despite its non-coding nature, LINC01102 has been shown to play a critical role in the regulation of gene expression. Studies have shown that LINC01102 can interact with protein-coding genes and regulate their gene expression. For example, LINC01102 has been shown to physically interact with the protein encoded by the gene IPAR-G, which is involved in the regulation of insulin sensitivity.

LINC01102 has also been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. For example, studies have shown that LINC01102 can be regulated by the stress hormone cortisol, and that it can influence the expression of genes involved in stress response.

In addition to its role in gene regulation, LINC01102 has also been shown to be involved in the regulation of post-transcriptional modifications (PTMs). PTMs are processes that involve the modification of RNA molecules after they have been transcribed from DNA, such as phosphorylation , ubiquitination, and covalent binding.

Studies have shown that LINC01102 can be regulated by PTMs, such as those associated with the protein of the same name (PTM-LINC01102). This suggests that LINC01102 may be a good candidate for drugs that target the regulation of PTMs.

In conclusion, LINC01102 is a non-coding RNA molecule that is characterized by its unique structure and its role in gene regulation and post-transcriptional modifications. Its study has identified a new potential drug target and may have implications for the development of new therapeutic strategies .

Protein Name: Long Intergenic Non-protein Coding RNA 1102

The "LINC01102 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01102 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets